Company Overview
- Headquarters
- 610, 610 Main Street,, Cambridge MA
- Website
- akriveiatx.com
- Phone
- (609) 560-0927
- Employees
- 7
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$5B
Who is Akriveia Therapeutics
Akriveia Therapeutics is a private company based in Cambridge, Massachusetts. The company employs 7 people. Akriveia Therapeutics focuses on developing better and safer immunotherapeutics. Their proprietary Aklusion™ platform restricts the action of therapeutic agents to the tumor site, aiming to minimize side effects associated with traditional immunotherapy. The company's technology was licensed from Thomas Jefferson University and City of Hope. Akriveia Therapeutics is seeking to expand the accessibility and efficacy of immunotherapy by enabling the use of potent drug combinations for longer treatment durations. To learn more about Akriveia Therapeutics, visit akriveiatx.com.
Company Leadership
Akriveia Therapeutics Industry Tags
Companies Similar to Akriveia Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to Akriveia Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 5M | 23 | Princeton, NJ | 1987 | |
| 5M | 21 | Waltham, MA | 1998 | |
| 5M | Las Vegas, NV | |||
| 5M | Baton Rouge, LA | |||
| 5M | 5 | Pittsburgh, PA | 2004 |